Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeys

Journal of Virology

Volumn 75, Issue 5, 2001, Pages 2462-2467

  Barouch, D H ^a   Craiu, A ^a   Santra, S ^a   Egan, M A ^a   Schmitz, J E ^a   Kuroda, M J ^a   Fu, T M ^a   Nam, J H ^a   Wyatt, L S ^a   Lifton, M A ^a   Krivulka, G R ^a   Nickerson, C E ^a   Lord, C I ^a   Moss, B ^a   Lewis, M G ^a   Hirsch, V M ^a   Shiver, J W ^a   Letvin, N L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; EPITOPE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; PLASMID DNA; VIRUS ANTIGEN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINATION; VIRUS STRAIN;

AIDS VACCINES; ANIMALS; EPITOPES, T-LYMPHOCYTE; GENE PRODUCTS, GAG; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; HIV-1; HUMANS; IMMUNODOMINANT EPITOPES; MACACA MULATTA; SAIDS VACCINES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION; VACCINES, DNA;

EID: 0035130148     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.5.2462-2467.2001     Document Type: Article

References (32)

1. Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from SIV
2. Phenotypic analysis of antigen-specific T lymphocytes
3. MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies
4. Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys
5. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination
6. Induction of CD8+ T cell responses to dominant and subdominant epitopes and protective immunity to Sendai virus infection by DNA vaccination
7. T cell receptor Vβ repertoire in an acute infection of rhesus monkeys with simian immunodeficiency viruses and a chimeric simian-human immunodeficiency virus
8. Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype
9. + cytotoxic T lympocytes specific for dominant and nondominant viral epitopes in simian-human immunodeficiency virus-infected rhesus monkeys
10. Protective cellular immunity: Cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization
11. Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen
12. Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes
13. Dramatic rise in plasma viremia after CD8+ T cell depletion in simian immunodeficiency virus-infected macaques
14. Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus
15. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
16. Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex
17. T cell responses and viral escape
18. Dissecting the immune response to Moloney murine sarcoma/leukemia virus-induced tumors by means of a DNA vaccination approach
19. Definition of an epitope and MHC class I molecule recognized by Gag-specific cytotoxic T lymphocytes in SIVmac-infected rhesus monkeys
20. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection
21. Quantitation of HIV-specific cytotoxic T lymphocytes and plasma load of viral RNA
22. Major expansion of CD8 + T cells with a predominant Vβ usage during the primary immune response to HIV
23. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys
24. An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys
25. Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations
26. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes
27. Humoral and cellular immunities elicited by HIV-1 DNA vaccination
28. Human immunodeficiency virus type 1 envelope glycoprotein-specific cytotoxic T lymphocytes in simian-human immunodeficiency virus-infected rhesus monkeys
29. Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model
30. Priming and boosting immunity to respiratory syncytial virus by recombinant replication-defective vaccinia virus MVA
31. A vaccine-elicited, single viral epitopespecific cytotoxic T lymphocyte response does not protect against intravenous, cell-free simian immunodeficiency virus challenge
32. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses